Aller au contenu principal
Accès ouvert déclaré 2025 article

Neonatal Microbiome: Early Colonization, Preterm Dysbiosis, and Clinical Implications

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

The neonatal microbiome constitutes a dynamic and rapidly evolving ecosystem that exerts profound effects on immune, metabolic, and neurodevelopmental processes during early life. This review synthesizes current evidence on the establishment, maturation, and functional roles of the neonatal microbiome, emphasizing the differences between preterm and term infants and their implications for neonatal diseases. Microbial colonization commences at birth and is shaped predominantly by maternal transmission, mode of delivery, feeding practices, and antibiotic exposure. The early assembly of oral and gut microbiota provides the foundation for immune education, intestinal barrier integrity, and metabolic homeostasis; however, disruptions during this critical developmental window are associated with adverse outcomes. Preterm infants exhibit delayed and dysbiotic microbial development, characterized by reduced diversity, enrichment of Proteobacteria, and depletion of short-chain fatty acid-producing taxa. These alterations are strongly implicated in the pathogenesis of necrotizing enterocolitis, sepsis, bronchopulmonary dysplasia, and neurodevelopmental impairment, predominantly through mechanisms involving exaggerated lipopolysaccharide—Toll-like receptor 4—nuclear factor kappa B signaling, impaired barrier function, and metabolic deficiencies. Advances in germ-free and gnotobiotic models, combined with multi-omics approaches, have elucidated key host–microbe interactions and mechanistic pathways underpinning neonatal health. However, major challenges persist in establishing causality, standardizing analytical methods, and translating mechanistic findings into effective clinical interventions. Understanding the neonatal microbiome as a central regulator of early-life programming holds promise for the development of microbiome-targeted preventive and therapeutic strategies in neonatal and pediatric medicine.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Neonatal Microbiome: Early Colonization, Preterm Dysbiosis, and Clinical Implications
Date Crossref
30/11/2025
Éditeur
The Korean Society of Neonatology
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Gut microbiota and healthInfant Nutrition and HealthNeonatal and Maternal Infections

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.